Clinical Nurse Specialist in Winfield, IL Accepting Medicare

3 Clinical Nurse Specialist nurses found. Showing 1 - 3

Dr. Mary Lynn Puchalski, DNP, APRN, CNS, NNP- Clinical Nurse Specialist - Neonatal Medicare: Not Enrolled in Medicare Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-6974    Fax: 630-933-6335

Elizabeth Ann Dillman, APRN Clinical Nurse Specialist - Neuroscience Medicare: Not Enrolled in Medicare Practice Location: 25 N Winfield Rd Ste 5, Winfield, IL 60190 Phone: 630-933-4306

Mrs. Alison M Keck, APRN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-3160

News Archive

New findings suggest balancing Chk1 activity will produce less toxic cancer drugs

A study published by The Burnham Institute in the September edition of Molecular Cell reports that a cell-cycle checkpoint protein, known to be activated by an important class of anticancer drugs, may play crucial roles in both the hampering of therapeutic actions and aiding cancer cells to "recover" and start dividing again after treatment with these drugs.

Cardiac myosin-binding protein C identified as potential new diagnostic biomarker for heart attacks

Though they remain a leading killer, heart attacks can be effectively treated provided they can be rapidly diagnosed following initial onset of symptoms. In a study appearing in this month's Molecular and Cellular Proteomics, researchers have identified cardiac myosin-binding protein C (cMyBP-C) as a potential new diagnostic biomarker for heart attacks, one that may be particularly valuable for mild attacks in which traditional diagnostic proteins may not be abundant enough.

Regional initiative targets syphilis

The Pan American Health Organization (PAHO) launched a new regional plan of action to eliminate congenital syphilis from the Americas during the Global Health Council conference "Youth and Health: Generation on the Edge," held June 1 to 4 in Washington, D.C.

Lotus receives Chinese SFDA approval for R-Bambuterol Hydrochloride Phase I human clinical trials

Lotus Pharmaceuticals, Inc., a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it received approval from the State Food and Drug Administration ("SFDA") Ethics Committee to commence Phase I human clinical trials of R-Bambuterol Hydrochloride, the Company's proprietary drug candidate for the treatment of asthma.

Researchers encourage efforts that benefit public health and environment

The number of extremely hot days in Eastern and Midwestern U.S. cities is projected to triple by mid-century, according to a new study led by University of Wisconsin-Madison researchers and published today in the Journal of the American Medical Association.

Read more Medical News

› Verified 2 days ago